BCAX affiliate plans sale of 18,750 common shares

BCAX affiliate Ryan Cohlhepp filed to sell up to 18,750 common shares through broker UBS Financial Services, Inc. The planned sale is tied to an Exercise of Stock Option and is scheduled for 08/10/2026 on NASDAQ, with an aggregate market value of $521,812.50.

Rhea-AI Filing Summary

BCAX affiliate Ryan Cohlhepp filed to sell up to 18,750 common shares through broker UBS Financial Services, Inc. The planned sale is tied to an Exercise of Stock Option and is scheduled for 08/10/2026 on NASDAQ, with an aggregate market value of $521,812.50.

Over the prior three months, Cohlhepp reported BCAX common stock sales of 12,500 shares for $253,648.75 on 05/15/2026, 28,214 shares for $817,584.36 on 07/08/2026, and 536 shares for $15,544.00 on 07/09/2026.

Key Figures

Planned shares to be sold: 18,750 shares Aggregate market value: $521,812.50 Sale on 05/15/2026: 12,500 shares for $253,648.75 +2 more

5 metrics

Planned shares to be sold 18,750 shares Common stock to be sold on 08/10/2026 linked to Exercise of Stock Option

Aggregate market value $521,812.50 Market value of 18,750 common shares planned for sale

Sale on 05/15/2026 12,500 shares for $253,648.75 Common stock sold during past 3 months

Sale on 07/08/2026 28,214 shares for $817,584.36 Common stock sold during past 3 months

Sale on 07/09/2026 536 shares for $15,544.00 Common stock sold during past 3 months

Key Terms

Exercise of Stock Option, Securities To Be Sold, Securities Sold During The Past 3 Months

3 terms

Exercise of Stock Option financial

"Common | 08/10/2026 | Exercise of Stock Option | Issuer"

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 08/10/2026 | Exercise"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months Ryan Cohlhepp"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BCAX shares does Ryan Cohlhepp plan to sell under this filing?

The filing reports that 18,750 BCAX common shares are planned for sale. These shares are tied to an Exercise of Stock Option and are expected to be sold on 08/10/2026 through UBS Financial Services on NASDAQ.

What is the aggregate market value of the BCAX shares planned for sale?

The planned sale has an aggregate market value of $521,812.50. This value relates to the 18,750 BCAX common shares to be sold on 08/10/2026 in connection with an Exercise of Stock Option transaction.

Which broker is handling the planned BCAX stock sale for Ryan Cohlhepp?

The broker listed is UBS Financial Services, Inc., located at Eleven Madison Avenue, 4th Floor, New York, NY 10010. UBS is identified in connection with the planned sale of 18,750 BCAX common shares on NASDAQ.

What BCAX stock sales has Ryan Cohlhepp reported in the past three months?

Cohlhepp reported selling 12,500 BCAX shares for $253,648.75 on 05/15/2026, 28,214 shares for $817,584.36 on 07/08/2026, and 536 shares for $15,544.00 on 07/09/2026, all common stock transactions.

On which market will the planned BCAX share sale occur and when?

The planned sale of 18,750 BCAX common shares is listed for NASDAQ on 08/10/2026. The transaction is associated with an Exercise of Stock Option and is routed through UBS Financial Services, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/10/2026 - 04:16 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002034665
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Bicara Therapeutics Inc.
SEC File Number	001-42271
Address of Issuer	116 HUNTINGTON AVENUE SUITE 703 BOSTON MASSACHUSETTS 02116
Phone	617-468-4219
Name of Person for Whose Account the Securities are To Be Sold	Cohlhepp Ryan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc Eleven Madison Avenue 4th Floor New York NY 10010	18750	521812.50	65703866	08/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/10/2026	Exercise of Stock Option	Issuer			18750	08/10/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ryan Cohlhepp 116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116	Common	05/15/2026	12500	253648.75
Ryan Cohlhepp 116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116	Common	07/08/2026	28214	817584.36
Ryan Cohlhepp 116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116	Common	07/09/2026	536	15544.00

144: Remarks and Signature

Remarks
Date of Notice	08/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc., as attorney-in-fact for Ryan Cohlhepp
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)